Immunology

  1. Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant

    1. Ryutaro Kotaki
    2. Yu Adachi
    3. Saya Moriyama
    4. Taishi Onodera
    5. Shuetsu Fukushi
    6. Takaki Nagakura
    7. Keisuke Tonouchi
    8. Kazutaka Terahara
    9. Lin Sun
    10. Tomohiro Takano
    11. Ayae Nishiyama
    12. Masaharu Shinkai
    13. Kunihiro Oba
    14. Fukumi Nakamura-Uchiyama
    15. Hidefumi Shimizu
    16. Tadaki Suzuki
    17. Takayuki Matsumura
    18. Masanori Isogawa
    19. Yoshimasa Takahashi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Waning immune responses against SARS-CoV-2 among vaccinees in Hong Kong

    1. Qiaoli Peng
    2. Runhong Zhou
    3. Yuewen Wang
    4. Meiqing Zhao
    5. Na Liu
    6. Shuang Li
    7. Haode Huang
    8. Dawei Yang
    9. Ka-Kit Au
    10. Hui Wang
    11. Kwan Man
    12. Kwok-Yung Yuen
    13. Zhiwei Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice

    1. Ashley Zani
    2. Adam D. Kenney
    3. Jeffrey Kawahara
    4. Adrian C. Eddy
    5. Xiao-Liang Wang
    6. Mahesh KC
    7. Mijia Lu
    8. Emily A. Hemann
    9. Jianrong Li
    10. Mark E. Peeples
    11. Luanne Hall-Stoodley
    12. Adriana Forero
    13. Chuanxi Cai
    14. Jianjie Ma
    15. Jacob S. Yount

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Structural basis for antibody resistance to SARS-CoV-2 omicron variant

    1. Gabriele Cerutti
    2. Yicheng Guo
    3. Lihong Liu
    4. Zhening Zhang
    5. Liyuan Liu
    6. Yang Luo
    7. Yiming Huang
    8. Harris H. Wang
    9. David D. Ho
    10. Zizhang Sheng
    11. Lawrence Shapiro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)

    1. Maya Imbrechts
    2. Winnie Kerstens
    3. Madina Rasulova
    4. Thomas Vercruysse
    5. Wim Maes
    6. Louanne Ampofo
    7. Karen Ven
    8. Jeroen Lammertyn
    9. Karen Vanhoorelbeke
    10. Nico Callewaert
    11. Johan Neyts
    12. Kai Dallmeier
    13. Paul Declerck
    14. Hendrik Jan Thibaut
    15. Nick Geukens

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies

    1. Anne-Cathrine S. Vogt
    2. Lukas Jörg
    3. Byron Martina
    4. Pascal S. Krenger
    5. Xinyue Chang
    6. Andris Zeltins
    7. Monique Vogel
    8. Mona O. Mohsen
    9. Martin F. Bachmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection

    1. Anurag Adhikari
    2. Arunasingam Abayasingam
    3. Chaturaka Rodrigo
    4. David Agapiou
    5. Elvis Pandzic
    6. Nicholas A Brasher
    7. Bentotage Samitha Madushan Fernando
    8. Elizabeth Keoshkerian
    9. Hui Li
    10. Ha Na Kim
    11. Megan Lord
    12. Gordona Popovic
    13. William Rawlinson
    14. Michael Mina
    15. Jeffrey J Post
    16. Bernard Hudson
    17. Nicole Gilroy
    18. Adam W. Bartlett
    19. Golo Ahlenstiel
    20. Branka Grubor-Bauk
    21. Dominic Dwyer
    22. Pamela Konecny
    23. Andrew R Lloyd
    24. Marianne Martinello
    25. Rowena A Bull
    26. Nicodemus Tedla

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

    1. Venkata-Viswanadh Edara
    2. Kelly E. Manning
    3. Madison Ellis
    4. Lilin Lai
    5. Kathryn M. Moore
    6. Stephanie L. Foster
    7. Katharine Floyd
    8. Meredith E. Davis-Gardner
    9. Grace Mantus
    10. Lindsay E. Nyhoff
    11. Sarah Bechnak
    12. Ghina Alaaeddine
    13. Amal Naji
    14. Hady Samaha
    15. Matthew Lee
    16. Laurel Bristow
    17. Matthew Gagne
    18. Jesmine Roberts-Torres
    19. Amy R. Henry
    20. Sucheta Godbole
    21. Arash Grakoui
    22. Marybeth Saxton
    23. Anne Piantadosi
    24. Jesse J. Waggoner
    25. Daniel C. Douek
    26. Nadine Rouphael
    27. Jens Wrammert
    28. Mehul S. Suthar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin

    1. Anna Ohradanova-Repic
    2. Rostislav Skrabana
    3. Laura Gebetsberger
    4. Gabor Tajti
    5. Peter Baráth
    6. Gabriela Ondrovičová
    7. Romana Praženicová
    8. Nikola Jantova
    9. Patricia Hrasnova
    10. Hannes Stockinger
    11. Vladimir Leksa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Immune escape of SARS-CoV-2 Omicron variant from mRNA vaccination-elicited RBD-specific memory B cells

    1. Aurélien Sokal
    2. Matteo Broketa
    3. Annalisa Meola
    4. Giovanna Barba-Spaeth
    5. Ignacio Fernández
    6. Slim Fourati
    7. Imane Azzaoui
    8. Andrea de La Selle
    9. Alexis Vandenberghe
    10. Anais Roeser
    11. Magali Bouvier-Alias
    12. Etienne Crickx
    13. Laetitia Languille
    14. Marc Michel
    15. Bertrand Godeau
    16. Sébastien Gallien
    17. Giovanna Melica
    18. Yann Nguyen
    19. Virginie Zarrouk
    20. Florence Canoui-Poitrine
    21. France Noizat-Pirenne
    22. Jérôme Megret
    23. Jean-Michel Pawlotsky
    24. Simon Fillatreau
    25. Etienne Simon-Lorière
    26. Jean-Claude Weill
    27. Claude-Agnès Reynaud
    28. Félix A. Rey
    29. Pierre Bruhns
    30. Pascal Chappert
    31. Matthieu Mahévas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 77 of 169 Next